Bacterial two-component signalling as a therapeutic target in drug design. Inhibition of NRII by the diphenolic methanes (bisphenols).

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-4615-4897-3_14PMID 10549373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emerging Resistance to Antimicrobial Agents in Gram-Positive Bacteria

  2012cited by this paper
• CURRENT APPROACHES TO OVERCOME BACTERIAL RESISTANCE

  1997cited by this paper
• Kinetic characterization of phosphotransfer between CheA and CheY in the bacterial chemotaxis signal transduction pathway.

  1997cited by this paper
• Kinetic Comparison of the Specificity of the Vancomycin Resistance Kinase VanS for Two Response Regulators, VanR and PhoB†

  1996cited by this paper
• Altered recognition mutants of the response regulator PhoB: a new genetic strategy for studying protein-protein interactions.

  1996cited by this paper
• Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.

  1996cited by this paper
• The new threats of Gram positive pathogens: re-emergence of things past.

  1996cited by this paper
• New directions in antibacterial research.

  1996cited by this paper
• New targets and strategies for the development of antibacterial agents.

  1996cited by this paper
• Trends in infectious diseases mortality in the United States.

  1996cited by this paper
• Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.

  1996cited by this paper
• Vancomycin-Resistant Staphylococcus aureus: Perspectives on Measures Needed for Control

  1996cited by this paper
• DRUG FIRMS RESTOCK ANTIBACTERIAL ARSENAL: Growing bacterial resistance, new disease threats spur improvements to existing drugs and creation of new classes

  1996cited by this paper
• Vancomycin-resistant enterococci.

  1996cited by this paper
• Antibiotic resistance in bacteria.

  1995cited by this paper
• Novel pathway for bacterial metabolism of bisphenol A. Rearrangements and stilbene cleavage in bisphenol A metabolism.

  1994cited by this paper
• Acetyl phosphate and the activation of two-component response regulators.

  1994cited by this paper
• Histidine and aspartate phosphorylation: two-component systems and the limits of homology.

  1994cited by this paper
• Reviving the antibiotic miracle?

  1994cited by this paper
• Hospital-acquired infections: diseases with increasingly limited therapies.

  1994cited by this paper
• Mutational analysis of the bacterial signal-transducing protein kinase/phosphatase nitrogen regulator II (NRII or NtrB)

  1993cited by this paper
• Inhibitors of two-component signal transduction systems: inhibition of alginate gene activation in Pseudomonas aeruginosa.

  1993cited by this paper
• Resistance to Antimicrobial DrugsA Worldwide Calamity

  1993cited by this paper
• The two-component pathway comes to eukaryotes.

  1993cited by this paper
• Antibiotic resistance in bacteria.

  1992cited by this paper
• Phosphorylation of bacterial response regulator proteins by low molecular weight phospho-donors.

  1992cited by this paper
• The microbial wars.

  1992cited by this paper
• Is cross regulation by phosphorylation of two-component response regulator proteins important in bacteria?

  1992cited by this paper
• Communication modules in bacterial signaling proteins.

  1992cited by this paper
• cis‐Unsaturated fatty acids specifically inhibit a signal‐transducing protein kinase required for initiation of sporulation in Bacillus subtilis

  1992cited by this paper
• Signal transduction in bacterial chemotaxis

  1992cited by this paper
• Signal transduction pathways involving protein phosphorylation in prokaryotes.

  1991cited by this paper
• Synthesis and Antifungal Activity of Bisphenolic Derivatives.

  1990cited by this paper
• Comparative chemotherapeutic activity of new fluorinated 4-quinolones and standard agents against a variety of bacteria in a mouse infection model.

  1989cited by this paper
• Protein phosphorylation and regulation of adaptive responses in bacteria.

  1989cited by this paper
• The Predictive Power of the Polygraph: The Lies Lie Detectors Tell

  1987cited by this paper
• In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria

  1985cited by this paper
• 4,4′-Isopropylidine-Bis[2-Isopropyl]Phenol, a New Inhibitor for Cell Wall Formation of Bacillus subtilis

  1976cited by this paper

• Roles of Two-Component Systems in Pseudomonas aeruginosa Virulence

  2021cites this paper
• Two-Component Signal Transduction Systems of Pathogenic Bacteria As Targets for Antimicrobial Therapy: An Overview

  2017cites this paper
• DRUGS AGAINST PATHOGENC MICROBES HAVING TWO-COMPONENT SYSTEM

  2017cites this paper
• Bacterial protein kinase inhibitors

  2010cites this paper
• Two-Component Signal Transduction and Chemotaxis

  2005cites this paper
• Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms.

  2004cites this paper
• Use of combinatorial library screening to identify inhibitors of a bacterial two-component signal transduction kinase

  2004cites this paper
• Cell Signalling in Prokaryotes and Lower Metazoa

  2004cites this paper
• Bacterial Signal Transduction: Two-Component Signal Transduction as a Model for Therapeutic Intervention

  2004cites this paper
• Two-component and phosphorelay signal-transduction systems as therapeutic targets.

  2002cites this paper
• Virulence- and antibiotic resistance-associated two-component signal transduction systems of Gram-positive pathogenic bacteria as targets for antimicrobial therapy.

  2002cites this paper
• Two-component signal transduction.

  2000cites this paper
• Inhibitors of bacterial two-component signalling systems

  2000influential citation
• The Mechanism of Action of Inhibitors of Bacterial Two-component Signal Transduction Systems*

  2000cites this paper
• Multiple Mechanisms of Action for Inhibitors of Histidine Protein Kinases from Bacterial Two-Component Systems

  1999cites this paper
• Two-Component Signal Transduction as a Target for Microbial Anti-Infective Therapy

  1998cites this paper